×
Development of an Atherogenic Metabolic Risk Factor Profile Associated With the Use of Atypical Antipsychotics PDF
$ 40.00
Development of an Atherogenic Metabolic Risk Factor Profile Associated With the Use of Atypical Antipsychotics PDF quantity
$ 40.00
×
Comparative Effects of 30 Antipsychotics on Risk of Catatonia: An Analysis of the WHO Pharmacovigilance Database PDF
$ 40.00
Comparative Effects of 30 Antipsychotics on Risk of Catatonia: An Analysis of the WHO Pharmacovigilance Database PDF quantity
$ 40.00
×
A Multisite Study of Initial Respiration Rate and Heart Rate as Predictors of Posttraumatic Stress Disorder PDF
$ 40.00
A Multisite Study of Initial Respiration Rate and Heart Rate as Predictors of Posttraumatic Stress Disorder PDF quantity
$ 40.00
×
Omega-3 Polyunsaturated Fatty Acid (PUFA) Status in Major Depressive Disorder With Comorbid Anxiety Disorders PDF
$ 40.00
Omega-3 Polyunsaturated Fatty Acid (PUFA) Status in Major Depressive Disorder With Comorbid Anxiety Disorders PDF quantity
$ 40.00
×
What Happens With Adverse Events During 6 Months of Treatment With Selective Serotonin Reuptake Inhibitors? PDF
$ 40.00
What Happens With Adverse Events During 6 Months of Treatment With Selective Serotonin Reuptake Inhibitors? PDF quantity
$ 40.00
×
Effects of Dextroamphetamine on Depression and Fatigue in Men With HIV: A Double-Blind, Placebo-Controlled Trial PDF
$ 40.00
Effects of Dextroamphetamine on Depression and Fatigue in Men With HIV: A Double-Blind, Placebo-Controlled Trial PDF quantity
$ 40.00
×
A Clinical Trial of a Psychoeducation Group Intervention for Patients With Borderline Personality Disorder PDF
$ 40.00
A Clinical Trial of a Psychoeducation Group Intervention for Patients With Borderline Personality Disorder PDF quantity
$ 40.00
×
Exaggerated Acquisition and Resistance to Extinction of Avoidance Behavior in Treated Heroin-Dependent Men PDF
$ 40.00
Exaggerated Acquisition and Resistance to Extinction of Avoidance Behavior in Treated Heroin-Dependent Men PDF quantity
$ 40.00
×
Successful Use of Electroconvulsive Therapy in the Setting of Multiple Risk Factors for Retinal Detachment PDF
$ 40.00
Successful Use of Electroconvulsive Therapy in the Setting of Multiple Risk Factors for Retinal Detachment PDF quantity
$ 40.00
×
Electroconvulsive Therapy Device Classification: Response to FDA Advisory Panel Hearing and Recommendations PDF
$ 40.00
Electroconvulsive Therapy Device Classification: Response to FDA Advisory Panel Hearing and Recommendations PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart